Albemarle (ALB) Stock Price, News & Analysis

18 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 2 sell ratings, 9 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" ALB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALB, but not buy additional shares or sell existing shares.
View ALB analyst ratings or view top-rated stocks.

18 brokers have issued twelve-month target prices for Albemarle's shares. Their ALB share price targets range from $120.00 to $403.00. On average, they predict the company's stock price to reach $200.16 in the next twelve months. This suggests a possible upside of 72.9% from the stock's current price.
View analysts price targets for ALB or view top-rated stocks among Wall Street analysts.

Albemarle's stock was trading at $144.48 at the start of the year. Since then, ALB stock has decreased by 19.9% and is now trading at $115.78.
View the best growth stocks for 2024 here.

Albemarle saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 14,130,000 shares, an increase of 17.1% from the December 15th total of 12,070,000 shares. Based on an average trading volume of 3,170,000 shares, the days-to-cover ratio is presently 4.5 days.
View Albemarle's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 14th 2024.
View our ALB earnings forecast.

Albemarle will be holding an earnings conference call on Thursday, February 15th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 647-362-9199.

Albemarle Co. (NYSE:ALB) announced its quarterly earnings results on Thursday, November, 2nd. The specialty chemicals company reported $2.74 earnings per share for the quarter, missing analysts' consensus estimates of $3.70 by $0.96. The specialty chemicals company had revenue of $2.31 billion for the quarter, compared to analyst estimates of $2.52 billion. Albemarle had a net margin of 33.63% and a trailing twelve-month return on equity of 36.09%. The firm's revenue for the quarter was up 10.5% compared to the same quarter last year. During the same period last year, the business earned $7.50 earnings per share.
Read the conference call transcript.

Albemarle announced a quarterly dividend on Monday, October 23rd. Shareholders of record on Friday, December 15th will be given a dividend of $0.40 per share on Tuesday, January 2nd. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.38%. The ex-dividend date is Thursday, December 14th.
Read our dividend analysis for ALB.

Albemarle (NYSE:ALB) pays an annual dividend of $1.60 per share and currently has a dividend yield of 1.38%. The company has been increasing its dividend for 29 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 5.67%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ALB will have a dividend payout ratio of 24.81% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ALB.

ETFs with the largest weight of Albemarle (NYSE:ALB) stock in their portfolio include Sprott Lithium Miners ETF (LITP), Global X Lithium & Battery Tech ETF (LIT), iShares Lithium Miners and Producers ETF (ILIT), First Trust NASDAQ Clean Edge Green Energy Index Fund (QCLN), VanEck Green Metals ETF (GMET), ALPS Clean Energy ETF (ACES), Optica Rare Earths & Critical Materials ETF (CRIT) and Sprott Energy Transition Materials ETF (SETM).

63 employees have rated Albemarle Chief Executive Officer Luther C. Kissam, IV on Glassdoor.com. Luther C. Kissam, IV has an approval rating of 75% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Albemarle investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), NVIDIA (NVDA), Rogers Communications (RCI) and Alibaba Group (BABA).

Albemarle's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Franklin Resources Inc. (4.42%), Primecap Management Co. CA (2.96%), Norges Bank (2.23%), Baillie Gifford & Co. (2.01%), Mirae Asset Global Investments Co. Ltd. (1.33%) and Dimensional Fund Advisors LP (1.14%). Insiders that own company stock include Eric Norris, J Kent Masters, John Clarence Barichivich III, Karen G Narwold, Karen G Narwold, Kristin M Coleman, Luther C Iv Kissam, Netha N Johnson, Raphael Goszcz Crawford and Scott Tozier.
View institutional ownership trends.

Shares of ALB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.